FDA Investigator Nancy T Waites
Nancy T Waites has inspections in 5 countries as of 15 Sep 2023. Nancy T Waites has collaborated with a combinined 2952 experts on various inspections, contributing to compliance and improvement across diverse sectors.
Investigator Details
Number of Inspected Sites:
17
Last Inspection Date:
15 Sep 2023
Investigator Role:
FDA Investigator
Redica ID:
Country:
Mexico,
United States of America,
Ireland,
Canada,
Switzerland
Co-Investigator(s):
Abby Lmozeke Baker,
Albert F Peacock, PhD,
Alicia Gilbert,
Alicia M Mozzachio,
Amber D Brodas,
Andrew Chang,
Anissa M Cheung,
Anita Narula, PhD,
Anita Verma,
Ann Marie Montemurro,
Ann Marie Schofield,
Antonina Aydanian,
Bijoy Panicker,
Binh T Nguyen,
Burnell M Henry,
Carl Lee,
Carmen Y Fisher,
CDR Donald Ertel,
Charles Jewell,
Christian D Lynch (CDL),
Christina J Sauder, PhD,
Christopher R Czajka,
Cynthia Jim, CSO,
Daniel J Roberts,
Daniel Lagasse,
Daryl A Dewoskin,
David M Beltran,
Deborah J Parris,
Deborah M Trout,
Decarlos A Gomez,
Demitria J Argiropoulos,
Demitria J Xiradakis,
Dennis E Guilfoyle, PhD,
Destry M Sillivan,
Diana Kouiavskaia,
Diane L Raccasi,
Donald L Lech,
Edmund F Mrak, Jr,
Eileen A Liu,
Ekaterina Allen,
Eliezar Ramos,
Elmina E Akwo,
Eric Peng,
Freyja V Lynn,
Garrad R Poole,
Gene D Arcy,
Helen B Ricalde,
Jacqueline Mdiaz Albertini,
Jacqueline S Warner,
James C Lee, PharmD,
James C Maclaughlin,
James E Keller, PhD,
James P Stumpff,
James R Evans,
Jeffrey M Watson,
Jennifer L Bridgewater,
Jennifer L Reed,
Joan A Loreng,
Joan Johnson,
John F Cipollo,
John M Mcinnis,
John P Mistler,
Joseph George,
Julie D Bringger,
Jun Park, PhD,
Karen L Kosar,
Katherine E Jacobitz,
Kathleen B Swat,
Katie Harris,
Kelly R Lewis,
Kevin A Gonzalez,
Kevin P Foley,
Kham Phommachanh,
Kristina J Donohue,
Kristina L Conroy,
Larry K Austin,
Lata C Mathew, PhD,
Laurel A Beer,
LCDR Debra Emerson,
Leslie D Wagner,
Lily Y Koo,
Linda Thai,
Lori P Peters,
Lori Peters,
Madushini Dharmasena, PhD,
Malgorzata G Norton,
Marc A Jackson, Jr,
Maria Joselopez Barragan, PhD,
Mariza M Jafary,
Marjorie A Shapiro, PhD,
Marsha W Major,
Martha T Olone,
Mary Davis Lopez,
Mate Tolnay,
Matthew A Spataro,
Megan A Haggerty,
Mercy O Quagraine,
Michael C Kennedy, PhD,
Michele L Forster, PhD,
Michele L Obert,
Mihaly S Ligmond,
Milan S Blake,
Minh D Phan,
Mohammad Heidaran, PhD,
Nancy E Kirschbaum,
Nicole K Trudel,
Nimmy Mathews,
Nobuko H Katagiri,
Olga Simakova,
Omotunde O Osunsanmi,
Patricia Fhughes Troost,
Patrick C Klotzbuecher,
Paul Mouris,
Paul W Keller,
Paula A Trost,
Perry T Nichols,
Prabhu P Raju,
Qing Joanna Zhou, PhD,
Rabia Ballica, PhD,
Ralph A Erickson,
Ramjay Vatsan, PhD,
Randa Melhem, PhD,
Randy L Clarida,
Raymond W Brullo,
Reyes Candau Chacon, PhD,
Richard Heath Coats,
Richard W Thornton,
Robert Aksamit, PhD,
Robert J Nesselhauf,
Robert Jennings,
Robert W Fisher,
Robert W Jennings,
Roger F Zabinski,
Roman Drews, PhD,
Roman T Drews, PhD,
Ronald E Lundquist,
Rose M Ashley,
Sarah B Tanksley,
Scott E Norris,
Scott T Ballard,
Sean R Bryd,
Sidney B Priesmeyer,
Simone E Pitts,
Stacey S Degarmo,
Stephanie A Slater, MS,
Steven C Derrick,
Sukhanya Jayachandra,
Sunitha K Rajaram, PhD,
Susan F Laska, MS,
Susan M Jackson,
Tamala P Bogan,
Tamala P Magee,
Thomas Finn, PhD,
Tina Buecklein,
Tina S Roecklein,
Toyin B Oladimeji,
Vijaya L Simhadri,
Wayne E Seifert,
William F Lagud, Jr,
Yasamin Ameri,
Yiping Jia,
Yvins Dezan,
Zuben E Sauna, PhD
Nancy T Waites's Documents
| Publish Date | Document Type | Title |
|---|---|---|
| June, 2011 | FDA 483 | Instituto Bioclon S.A. de C.V. - Form 483, 2011-06-22 |
| February, 2015 | FDA 483 | Biovex, Inc. - Form 483, 2015-02-13 |
| February, 2015 | FDA 483 Response | Biovex, Inc. - Form 483R, 2015-02-27 |
| November, 2010 | FDA 483 | MedImmune Vaccines, Inc - Form 483, 2010-11-05 |
| February, 2015 | EIR | Biovex, Inc. - EIR, 2015-02-13 |
| April, 2009 | EIR | Instituto Bioclon S.A. de C.V. - EIR, 2009-04-24 |
Experience Redica System's NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more